Literature DB >> 12216327

Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Jacqueline de Graaf1, Mario J Veerkamp, Anton F H Stalenhoef.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12216327      PMCID： PMC1308945     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  52 in total

1.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

Authors:  A Tchernof; B Lamarche; D Prud'Homme; A Nadeau; S Moorjani; F Labrie; P J Lupien; J P Després
Journal:  Diabetes Care       Date:  1996-06       Impact factor: 19.112

3.  Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.

Authors:  S Venkatesan; P Cullen; P Pacy; D Halliday; J Scott
Journal:  Arterioscler Thromb       Date:  1993-07

4.  The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.

Authors:  M J Hoffer; S J Bredie; D I Boomsma; P W Reymer; J J Kastelein; P de Knijff; P N Demacker; A F Stalenhoef; L M Havekes; R R Frants
Journal:  Atherosclerosis       Date:  1996-01-26       Impact factor: 5.162

Review 5.  Insulin resistance and lipoprotein metabolism.

Authors:  M R Taskinen
Journal:  Curr Opin Lipidol       Date:  1995-06       Impact factor: 4.776

6.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

7.  Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture.

Authors:  H Hauner; T Petruschke; M Russ; K Röhrig; J Eckel
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

8.  Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.

Authors:  M A Austin; E Wijsman; S W Guo; R M Krauss; J D Brunzell; S Deeb
Journal:  Genet Epidemiol       Date:  1991       Impact factor: 2.135

9.  Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.

Authors:  G F Lewis; K D Uffelman; L W Szeto; B Weller; G Steiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

10.  Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.

Authors:  S Reynisdottir; M Eriksson; B Angelin; P Arner
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808
View more
  7 in total

1.  Dynamics of human adipose lipid turnover in health and metabolic disease.

Authors:  Peter Arner; Samuel Bernard; Mehran Salehpour; Göran Possnert; Jakob Liebl; Peter Steier; Bruce A Buchholz; Mats Eriksson; Erik Arner; Hans Hauner; Thomas Skurk; Mikael Rydén; Keith N Frayn; Kirsty L Spalding
Journal:  Nature       Date:  2011-09-25       Impact factor: 49.962

2.  FABP4 plasma levels are increased in familial combined hyperlipidemia.

Authors:  Anna Cabré; Iolanda Lázaro; Montserrat Cofán; Estibaliz Jarauta; Núria Plana; Angel L Garcia-Otín; Juan F Ascaso; Raimón Ferré; Fernando Civeira; Emilio Ros; Lluís Masana
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

3.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

4.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

5.  A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.

Authors:  Christopher L Plaisier; Steve Horvath; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Miguel F Herrera; Teresa Tusie-Luna; Carlos Aguilar-Salinas; Päivi Pajukanta
Journal:  PLoS Genet       Date:  2009-09-11       Impact factor: 5.917

6.  Adipocyte triglyceride turnover is independently associated with atherogenic dyslipidemia.

Authors:  Keith Frayn; Samuel Bernard; Kirsty Spalding; Peter Arner
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

7.  Atypical presentation of a middle age male with severe hypertriglyceridaemia: a case report.

Authors:  Ali I Albahrani; Jannette Usher J; Eileen Marks; L Ranganath; Alan Shenkin
Journal:  J Med Case Rep       Date:  2007-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.